BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc., a bio-therapeutics company utilizing its proprietary process technologies to develop and commercialize improved protein therapeutics, announced today the appointment of Jon S. Saxe to its Board of Directors.
